News
Dassault Systèmes Launches SOLIDWORKS SkillForce, Its Global Initiative to Empower Students in Work-Based Learning
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the launch of SOLIDWORKS SkillForce, its new global initiative to provide licenses of its SOLIDWORKS applications to
Dassault Systèmes Reveals the Next Dimension of Product Design and Manufacturing with Apple Vision Pro
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), the world leader in Virtual Twin Experience, today announced that 3D UNIV+RSES powered by the 3DEXPERIENCE platform will leverage the power
Dassault Systèmes Introduces SOLIDWORKS CPQ, Its AI-Powered Business Solution for Fast and Accurate Configure, Price and Quote Capabilities
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the launch of SOLIDWORKS CPQ, its new configure, price and quote solution on the 3DEXPERIENCE platform. SOLIDWORKS CPQ
Dassault Systèmes Announces Centric Software’s Acquisition of AI-Powered PXM Solution, Contentserv
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that its subsidiary Centric Software, the Product Lifecycle Management (PLM) market leader, has signed an agreement to
Dassault Systèmes and KUKA Partner to Boost Robotics and Automation Efficiency for Manufacturers
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its partnership with the global industrial automation and robotics company KUKA to provide manufacturing industries with
Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis™ LCS, at the European Congress of Radiology
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
Dassault Systèmes’ 3DEXPERIENCE World 2025 to Explore the AI-Powered Generative Economy
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced 3DEXPERIENCE World 2025, its annual event dedicated to the SOLIDWORKS and 3DEXPERIENCE platform user community, is taking
ESKER: Implementation Of The Squeeze-Out For The Shares Of The Company
Following the public tender offer initiated by
Boréal Bidco SAS
This press release has been prepared and published on 18 February 2025 pursuant to Article 237-3 III of the Autorité des
Prodware: Strong Growth Continues in 2024
BILENDI: The latest version of Bilendi Discuss fully automates market research studies from initial objective to final report using AI
Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances
Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and transforming patient experiences across the entire clinical development process
Dassault Systèmes and Volkswagen Group Implement the 3DEXPERIENCE Platform to Optimize Vehicle Development
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Volkswagen Group today announced a long-term partnership to advance Volkswagen Group’s digital infrastructure for state-of-the-art
Dassault Systèmes Reveals “3D UNIV+RSES” and Related AI-Based Services
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today opened up its new horizon as part of the Generative Economy by introducing “3D UNIV+RSES” that embed multiple generative AI
BILENDI: Bilendi announces the completion of the acquisition of Netquest
Median Technologies: eyonis™ Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions
Regulatory News:
Median Technologies (Paris:ALMDT):
Fredrik Brag, CEO of Median Technologies, will host two webcasts on February 4, 2025
“New Horizons in Fighting Lung Cancer: eyonis™ LCS
Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME scheme eligible), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device
Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis™ regulatory filings and commercialization in U.S. and EU
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
BILENDI: Launch of Bilendi Platform: Redefining Efficiency in Market Research
Medidata Expands Leadership Team to Drive Patient-Centered and Customer-Focused Innovation
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has named Alicia Staley as chief patient officer and senior vice president
Verimatrix gibt Einführung der Over-the-Air-CAS-Nachrüstlösung DVB ReAccess bekannt
Verimatrix, (Euronext Paris: VMX, FR0010291245), das führende Unternehmen im Bereich der modernen vernetzten Welt mit menschenzentrierter Sicherheit, gab heute die allgemeine Verfügbarkeit seiner
Verimatrix Announces Release of DVB ReAccess Over-the-Air CAS Retrofit Solution
Regulatory News:
Verimatrix, (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with people-centered security, today announced general availability of its new
Median Technologies: Financial Communications Schedule for the First Half of 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:
Publication
Date
2024
BILENDI: Bilendi launches a US panel as part of its panel expansion strategy
ClinChoice verlängert 13-jährige Partnerschaft mit Medidata – Ergänzung von Clinical Data Studio zur Optimierung des Datenmanagements und Stärkung der Fähigkeiten im Bereich klinischer Studien
Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Life-Science-Branche, erneuert seine langjährige Unternehmenspartnerschaft mit dem




